Skip to main content

Table 4 Clinic location and number and percentage of dogs enrolled in a clinical field study investigating the efficacy and safety of combination chewable tablets administered orally once a month for 11 months for the prevention of heartworm disease in client-owned dogs presented in the USA

From: Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs

Clinic location

Moxidectin/Sarolaner/Pyrantel combination product

Heartgard® Plus

Total

n

%

n

%

n

%

Lake Worth, FL

12

4.4

6

4.3

18

4.4

West Palm Beach, FL

8

2.9

4

2.9

12

2.9

Boca Raton, FL

8

2.9

4

2.9

12

2.9

Bogart, GA

14

5.1

7

5.1

21

5.1

Baton Rouge 1, LA

9

3.3

4

2.9

13

3.2

Baton Rouge 2, LA

8

2.9

4

2.9

12

2.9

Livonia, LA

13

4.8

6

4.3

19

4.6

Metairie, LA

10

3.7

5

3.6

15

3.7

Zachary, LA

10

3.7

5

3.6

15

3.7

Wichita Falls, TX

8

2.9

4

2.9

12

2.9

Grapevine, TX

10

3.7

5

3.6

15

3.7

Lawrence, KS

8

2.9

4

2.9

12

2.9

Bartlesville, OK

20

7.4

10

7.2

30

7.3

Fort Collins, CO

10

3.7

5

3.6

15

3.7

Terre Haute, IN

11

4.0

6

4.3

17

4.1

Farragut, TN

10

3.7

6

4.3

16

3.9

Raleigh, NC

12

4.4

6

4.3

18

4.4

Springfield, MO

26

9.6

14

10.1

40

9.8

Quakertown, PA

23

8.5

12

8.7

35

8.5

Chester, CT

10

3.7

5

3.6

15

3.7

Caledonia, MI

12

4.4

6

4.3

18

4.4

Grand Rapids 1, MI

10

3.7

5

3.6

15

3.7

Grand Rapids 2, MI

10

3.7

5

3.6

15

3.7

Total

272

100

138

100

410

100